FDA-Drug2026-08-12Class IIPROCESSING DEFECT
Aurobindo Dicyclomine Hydrochloride 10mg capsules recalled for empty capsules
What this means
Aurobindo Pharma USA is recalling Dicyclomine Hydrochloride Capsules 10mg (Batch DMC125018A, expiration 07/2027) because some bottles contain empty capsules instead of the medication. The issue affects approximately 6,408 bottles distributed nationwide.
- Check if you have Dicyclomine from this batch (look for NDC 59651-719-99 and batch number DMC125018A on the label).
- Do not take capsules from an affected bottle.
- Contact your pharmacy or doctor for a replacement or alternative medication.
- Return the affected bottle to your pharmacy.
The agency's original wording
Hazard
shortfill; reports of empty capsules.
Intended for
Adults
Illnesses reported
None reported
Sold states
US Nationwide.
Affected count
6,408 bottles distributed to market
Manufactured in
279 Princeton Hightstown Rd, East Windsor, NJ, United States
Products
Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0733-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.